Foster Meredith C, Inker Lesley A, Hsu Chi-Yuan, Eckfeldt John H, Levey Andrew S, Pavkov Meda E, Myers Bryan D, Bennett Peter H, Kimmel Paul L, Vasan Ramachandran S, Coresh Josef, Nelson Robert G
Tufts Medical Center, Boston, MA.
University of California, San Francisco, San Francisco, CA.
Am J Kidney Dis. 2015 Jul;66(1):75-83. doi: 10.1053/j.ajkd.2015.01.013. Epub 2015 Mar 12.
A growing number of serum filtration markers are associated with mortality and end-stage renal disease (ESRD) in adults. Whether β-trace protein (BTP) and β2-microglobulin (B2M) are associated with these outcomes in adults with type 2 diabetes is not known.
Longitudinal cohort study.
SETTING & PARTICIPANTS: 250 Pima Indians with type 2 diabetes (69% women; mean age, 42 years; mean diabetes duration, 11 years).
Serum BTP, B2M, and glomerular filtration rate measured by iothalamate clearance (mGFR) or estimated using creatinine (eGFRcr) or cystatin C level (eGFRcys).
OUTCOMES & MEASUREMENTS: Incident ESRD and all-cause mortality through December 2013. HRs were reported per interquartile range decrease of the inverse of BTP and B2M (1/BTP and 1/B2M) using Cox regression. Improvement in risk prediction with the addition of BTP or B2M level to established markers (eGFRcys with mGFR or eGFRcr) was evaluated using C statistics, continuous net reclassification improvement, and relative integrated discrimination improvement (RIDI).
During a median follow-up of 14 years, 69 participants developed ESRD and 95 died. Both novel markers were associated with ESRD in multivariable models. BTP level remained statistically significant after further adjustment for mGFR (1/BTP, 1.53 [95% CI, 1.01-2.30]; 1/B2M, 1.54 [95% CI, 0.98-2.42]). B2M level was associated with mortality in multivariable models and after further adjustment for mGFR (HR, 2.12; 95% CI, 1.38-3.26). The addition of B2M level to established markers increased the C statistic for mortality but only weakly when assessed by either continuous net reclassification improvement or RIDI; none was improved for ESRD by the addition of these markers.
Small sample size, single measurements of markers.
In Pima Indians with type 2 diabetes, BTP and, to a lesser extent, B2M levels were associated with ESRD. B2M level was associated with mortality after adjustment for traditional risk factors and established filtration markers. Further studies are warranted to confirm whether inclusion of B2M level in a multimarker approach leads to improved risk prediction for mortality in this population.
越来越多的血清滤过标志物与成人的死亡率和终末期肾病(ESRD)相关。β-微量蛋白(BTP)和β2-微球蛋白(B2M)是否与2型糖尿病成人的这些结局相关尚不清楚。
纵向队列研究。
250名皮马族2型糖尿病印第安人(69%为女性;平均年龄42岁;平均糖尿病病程11年)。
通过碘他拉酸盐清除率测定的血清BTP、B2M和肾小球滤过率(mGFR),或使用肌酐(eGFRcr)或胱抑素C水平(eGFRcys)估算的肾小球滤过率。
至2013年12月的新发ESRD和全因死亡率。使用Cox回归报告BTP和B2M倒数(1/BTP和1/B2M)每降低一个四分位数间距的风险比(HR)。使用C统计量、连续净重新分类改善和相对综合判别改善(RIDI)评估在既定标志物(mGFR或eGFRcr的eGFRcys)基础上增加BTP或B2M水平对风险预测的改善情况。
在中位随访14年期间,69名参与者发生了ESRD,95人死亡。在多变量模型中,这两种新标志物均与ESRD相关。在进一步调整mGFR后,BTP水平仍具有统计学意义(1/BTP,1.53[95%CI,1.01 - 2.30];1/B2M,1.54[95%CI,0.98 - 2.42])。在多变量模型中以及进一步调整mGFR后,B2M水平与死亡率相关(HR,2.12;95%CI,1.38 - 3.26)。在既定标志物基础上增加B2M水平可提高死亡率的C统计量,但通过连续净重新分类改善或RIDI评估时仅略有提高;添加这些标志物对ESRD的预测无改善。
样本量小,标志物单次测量。
在皮马族2型糖尿病印第安人中,BTP以及程度较轻的B2M水平与ESRD相关。在调整传统危险因素和既定滤过标志物后,B2M水平与死亡率相关。有必要进一步研究以确认在多标志物方法中纳入B2M水平是否能改善该人群的死亡风险预测。